Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130307 · ClinicalTrials.gov registry record · NA
Virtual Reality Analgesia for Brief Thermal Pain
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT05130307: Completed NA study, sponsored by University of Washington.
NCT05130307 is a NA study that has completed, run by University of Washington. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130307, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.
Primary Outcome
Baseline, Worst pain rating using a single graphic rating scale, 0 = no pain, 10 = excruciating pain
Interventions
- BEHAVIORAL virtual reality game
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
What the finished NCT05130307 record still lists
NCT05130307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which virtual reality game is the first listed.
NCT05130307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05130307 about?
NCT05130307 is a clinical study titled "Virtual Reality Analgesia for Brief Thermal Pain". Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.
What is the current status of trial NCT05130307?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2022-04-25. Estimated completion is 2022-06-03.
What interventions are being tested in trial NCT05130307?
The interventions under investigation include: virtual reality game (BEHAVIORAL).
Who is sponsoring clinical trial NCT05130307?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05130307's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI